Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Increased
Reduced
Net increased
Funds Holding
4,858
Funds Holding Change
+17
Funds Holding Growth
+0.4%
Value
$1.49T
Holding in Top 10
1,281
Top 10 Change
+178
Top 10 Growth
+16%
Value Growth
-0.3%
New
184
Increased
2,284
Reduced
2,071
Closed
106
Capital Inflow
$52.9B
Capital Outflow
$48.6B
Net Capital Flow
+$4.31B
Capital Flow Change
-$18.6B
Calls
$21.7B
Puts
$19.3B
Net Calls
+$2.48B
Put/Call Ratio
0.89